Biotoxtech Co., Ltd. (KOSDAQ:086040)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,995.00
-35.00 (-1.16%)
At close: Mar 28, 2025, 3:30 PM KST
-53.06%
Market Cap 47.08B
Revenue (ttm) 41.34B
Net Income (ttm) -6.43B
Shares Out 15.72M
EPS (ttm) -405.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,617
Average Volume 18,462
Open 3,035.00
Previous Close 3,030.00
Day's Range 2,985.00 - 3,035.00
52-Week Range 2,905.00 - 6,800.00
Beta 0.36
RSI 41.37
Earnings Date Mar 20, 2025

About Biotoxtech

Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea. It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development. The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and de... [Read more]

Industry Medical Laboratories
Founded 2000
Employees 198
Stock Exchange KOSDAQ
Ticker Symbol 086040
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.